Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $20.3900 (-2.02%) ($19.8100 - $20.6400) on Tue. Aug. 4, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.08% (three month average) | RSI | 36 | Latest Price | $20.3900(-2.02%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -0.4% a day on average for past five trading days. | Weekly Trend | TGTX declines -5.9% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(63%) ARKG(58%) ARKK(56%) IWO(56%) IBB(55%) | Factors Impacting TGTX price | TGTX will decline at least -3.04% in a week (0% probabilities). VIXM(-34%) VXX(-32%) UUP(-18%) DRIV(-5%) XLC(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.04% (StdDev 6.08%) | Hourly BBV | 0 () | Intraday Trend | -1% | | | |
|
1 - 5 Day Possible Target | $8.78(-56.94%) | Resistance Level | $21.72 | 5 Day Moving Average | $20.01(1.9%) | 10 Day Moving Average | $20.65(-1.26%) | 20 Day Moving Average | $21.72(-6.12%) | To recent high | -15.6% | To recent low | 63.6% | Market Cap | $2.582b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |